Finance

Lists
CLNN:NASDAQ
Clene Inc
$4.37
+4.30%
(+0.18) 1D
Aug 20, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLNN...
Open
$4.24
High
$4.37
Low
$4.10
Mkt. cap
55.36M
Avg. vol.
77.47K
Volume
23.07K
52-wk high
$13.50
52-wk low
$3.88
EPS
-$3.18
Beta
0.96
Shares outstanding
12.85M
No. of employees
78
Open
$4.24
High
$4.37
Low
$4.10
Mkt. cap
55.36M
Avg. vol.
77.47K
Volume
23.07K
52-wk high
$13.50
52-wk low
$3.88
EPS
-$3.18
Beta
0.96
Shares outstanding
12.85M
No. of employees
78
News stories
From web sources and news partners
About Clene Inc
CEO-
Employees78
Founded2013
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websiteclene.com
Analyst ratings
Based on 4 analysts giving stock ratings to CLNN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CLNN in the last 3 months.
Highest
Current $4.37
$31.00 (+609.38%)
Average
$27.75 (+535.01%)
Lowest
$20.00 (+357.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
$20.00
+357.7%
08/18/2026
Justin Walsh
JonesTrading
Buy
Maintained
$30.00
+586.5%
08/18/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$30.00
+586.5%
08/17/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$31.00
+609.4%
08/11/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$50.00
+1,044.2%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
15.00K
77.00K
15.00K
90.00K
Cost of goods sold
-
23.00K
-
36.00K
Cost of revenue
-
23.00K
-
36.00K
Research and development expenses
3.51M
5.50M
329.00K
3.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.15M
2.05M
1.75M
1.93M
Operating expense
5.66M
7.55M
2.08M
5.40M
Total operating expenses
5.66M
7.57M
2.08M
5.44M
Operating income
-5.65M
-7.50M
-2.06M
-5.35M
Other non operating income
-2.52M
-1.02M
-5.29M
-7.44M
EBT including unusual items
-8.78M
-9.23M
-8.09M
-13.42M
EBT excluding unusual items
-8.78M
-9.23M
-8.09M
-13.42M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.78M
-9.23M
-8.09M
-13.42M
Net profit margin
-58,513.33%
-11,981.82%
-53,940.00%
-14,915.56%
Earnings per share
-0.61
-0.78
-0.24
-0.48
Interest and investment income
40.00K
40.00K
47.00K
55.00K
Interest expense
-649.00K
-746.00K
-791.00K
-695.00K
Net interest expenses
-609.00K
-706.00K
-744.00K
-640.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.28M
-7.14M
-1.71M
-4.99M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps